Hematoma Interleukin-1 Receptor Antagonist Concentrations Predict Long-Term Outcome in Acute Human Intracerebral Hemorrhage.

Saved in:
Bibliographic Details
Title: Hematoma Interleukin-1 Receptor Antagonist Concentrations Predict Long-Term Outcome in Acute Human Intracerebral Hemorrhage.
Authors: Parry-Jones AR; Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK., Nyakutsikwa B; Centre for Biostatistics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Askenase MH; Department of Immunobiology, Yale University School of Medicine, New Haven, CT., Gittins M; Centre for Biostatistics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Newland M; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Crilly S; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Kasher PR; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Davidson Y; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Roncaroli F; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Allan SM; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Sansing LH; Department of Neurology, Yale University School of Medicine, New Haven, CT., Ziai W; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD., Hanley DF; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Corporate Authors: INFLAME‐ICH Investigators
Source: Annals of neurology [Ann Neurol] 2026 May 03. Date of Electronic Publication: 2026 May 03.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-8249
DOI:10.1002/ana.78237